Surface forces are used to investigate the polymer conformation and the surface charge of polyelectrolyte multilayers. Films are prepared from strong polyelectrolytes with low and high linear charge density at 0.1 M NaCl, namely poly(diallyldimethylammonium) (PDADMA) and poly(styrenesulfonate) (PSS). The multilayer has two growth regimes: in the beginning, the film can contain as many positive as negative monomers. After about 15 deposited layer pairs, a linear growth regime characterized by an excess of cationic PDADMA monomers occurs. Independent of the film composition, at preparation conditions, the film surface is flat, uncharged and partially hydrophobic. Surface force measurements at decreased ionic strength provide insight. For PSS-terminated films electrostatic forces are found. At the beginning of multilayer formation, the surface charge density is negative. However, in the linear growth regime it is positive and low (one charge per 200−400 nm 2 ). This reversal of surface charge density of PSS-terminated films is attributed to excess PDADMA-monomers within the film. PDADMA terminated films show steric forces, chains protrude into the solution and form a pseudobrush, which scales as a polyelectrolyte brush with a low grafting density (1900 nm 2 per chain). We suggest a model of polyelectrolyte multilayer formation: PDADMA with its low linear charge density adsorbs with weakly bound chains. Monovalent anions within the film compensate PDADMA monomer charges. When PSS adsorbs onto a PDADMA-terminated multilayer, PSS monomers replace monovalent anions. While electrostatic bonds are formed and dissolved within the polyelectrolyte multilayer, the surface charge density remains zero.
The preparation, characterization, and surface modification of upconverting lanthanide-doped hexagonal NaGdF4 nanocrystals attached to light sensitive diiodido-Pt(IV) complexes is presented. The evaluation for photoactivation and cytotoxicity of the novel carboxylated diiodido-Pt(IV) cytotoxic prodrugs by near-infrared (NIR) light (λ = 980 nm) is also reported. We attempted two different strategies for attachment of light-sensitive diiodido-Pt(IV) complexes to Yb,Er- and Yb,Tm-doped β-NaGdF4 upconverting nanoparticles (UCNPs) in order to provide nanohybrids, which offer unique opportunities for selective drug activation within the tumor cells and subsequent spatiotemporal controlled drug release by NIR-to-visible light-upconversion: (A) covalent attachment of the Pt(IV) complex via amide bond formation and (B) carboxylate exchange of oleate on the surface of the UCNPs with diiodido-Pt(IV) carboxylato complexes. Initial feasibility studies showed that NIR applied by a 980 nm laser had only a slight effect on the stability of the various diiodido-Pt(IV) complexes, but when UCNPs were present more rapid loss of the ligand-metal-charge transfer (LMCT) bands of the diiodido-Pt(IV) complexes was observed. Furthermore, Pt released from the Pt(IV) complexes platinated calf-thymus DNA (ct-DNA) more rapidly when NIR was applied compared to dark controls. Of the two attachment strategies, method A with the covalently attached diiodido-Pt(IV) carboxylates via amide bond formation proved to be the most effective method for generating UCNPs that release Pt when irradiated with NIR; the released Pt was also able to bind irreversibly to calf thymus DNA. Nonetheless, only ca. 20% of the Pt on the surface of the UCNPs was in the Pt(IV) oxidation state, the rest was Pt(II), indicating chemical reduction of the diiodido-Pt(IV) prodrug by the UCNPs. Cytotoxicity studies with the various UCNP-Pt conjugates and constructs, tested on human leukemia HL60 cells in culture, indicated a substantial increase in cytotoxicity when modified UCNPs were combined with five rounds of 30 min irradiation with NIR compared to dark controls, but NIR alone also had a significant cytotoxic effect at this duration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.